Your browser doesn't support javascript.
loading
Risk estimation of uniparental disomy of chromosome 14 or 15 in a fetus with a parent carrying a non-homologous Robertsonian translocation. Should we still perform prenatal diagnosis?
Moradkhani, Kamran; Cuisset, Laurence; Boisseau, Pierre; Pichon, Olivier; Lebrun, Marine; Hamdi-Rozé, Houda; Maurin, Marie-Laure; Gruchy, Nicolas; Manca-Pellissier, Marie-Christine; Malzac, Perrine; Bilan, Frédéric; Audrezet, Marie-Pierre; Saugier-Veber, Pascale; Fauret-Amsellem, Anne-Laure; Missirian, Chantal; Kuentz, Paul; Egea, Gregory; Guichet, Agnès; Creveaux, Isabelle; Janel, Caroline; Harzallah, Ines; Touraine, Renaud; Goumy, Carole; Joyé, Nicole; Puechberty, Jacques; Haquet, Emmanuelle; Chantot-Bastaraud, Sandra; Schmitt, Sébastien; Gosset, Philippe; Duban-Bedu, Bénédicte; Delobel, Bruno; Vago, Philippe; Vialard, François; Gomes, Denise Molina; Siffroi, Jean-Pierre; Bonnefont, Jean-Paul; Dupont, Jean-Michel; Jonveaux, Philippe; Doco-Fenzy, Martine; Sanlaville, Damien; Le Caignec, Cédric.
Affiliation
  • Moradkhani K; Service de Génétique Médicale, CHU Nantes, Nantes, France.
  • Cuisset L; Laboratory of Genetics and Molecular Biology, Institute Cochin and Cochin Hospital, APHP, Paris Descartes University, Paris, France.
  • Boisseau P; Service de Génétique Médicale, CHU Nantes, Nantes, France.
  • Pichon O; Service de Génétique Médicale, CHU Nantes, Nantes, France.
  • Lebrun M; Service de Génétique-Laboratoire de Biologie Moléculaire, CHU-Hôpital Nord, Saint-Etienne, France.
  • Hamdi-Rozé H; Department of Molecular Genetics and Genomics, CHU Rennes, Rennes, France.
  • Maurin ML; Service d'Histologie, Embryologie, Cytogénétique., Groupe Hospitalier Necker-Enfants Malades, Paris, France.
  • Gruchy N; Service de Génétique, CHU Caen, Université Caen Normandie, Caen, France.
  • Manca-Pellissier MC; Département de Génétique Médicale, Assistance Publique- Hôpitaux de Marseille, Marseille, France.
  • Malzac P; Département de Génétique Médicale, Assistance Publique- Hôpitaux de Marseille, Marseille, France.
  • Bilan F; Service de Génétique, CHU de Poitiers, Poitiers, France.
  • Audrezet MP; Laboratoire de Génétique Moléculaire, CHRU, INSERM U1078, Brest, France.
  • Saugier-Veber P; Department of Genetics, Normandy Centre for Genomic Medicine and Personalized Medicine, Rouen University Hospital, Rouen, France.
  • Fauret-Amsellem AL; Department of Genetics, Robert-Debré Teaching Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Missirian C; Département de Génétique Médicale, Assistance Publique- Hôpitaux de Marseille, Marseille, France.
  • Kuentz P; Génétique Biologique Histologie, Centre Hospitalier Universitaire de Besançon, Besançon, France.
  • Egea G; Laboratoire de Biologie Médicale GEN-BIO, Clermont-Ferrand, France.
  • Guichet A; Service de Génétique, CHU Angers, Angers, France.
  • Creveaux I; Department of Biochemistry and Molecular Genetics, CHU Clermont-Ferrand, Clermont-Ferrand, France.
  • Janel C; Department of Biochemistry and Molecular Genetics, CHU Clermont-Ferrand, Clermont-Ferrand, France.
  • Harzallah I; Service de Génétique-Laboratoire de Biologie Moléculaire, CHU-Hôpital Nord, Saint-Etienne, France.
  • Touraine R; Service de Génétique-Laboratoire de Biologie Moléculaire, CHU-Hôpital Nord, Saint-Etienne, France.
  • Goumy C; Cytogénétique Médicale, CHU Estaing, Clermont-Ferrand, France.
  • Joyé N; U1240 Imagerie Moléculaire et Stratégies Théranostiques, Université Clermont Auvergne, INSERM, Clermont-Ferrand, France.
  • Puechberty J; Physiopathologie des Maladies Génétiques d'Expression Pédiatrique, Sorbonne Université, INSERM, Paris, France.
  • Haquet E; Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de Montpellier, Montpellier, France.
  • Chantot-Bastaraud S; Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de Montpellier, Montpellier, France.
  • Schmitt S; Physiopathologie des Maladies Génétiques d'Expression Pédiatrique, INSERM, Paris, France.
  • Gosset P; Service de Génétique Médicale, CHU Nantes, Nantes, France.
  • Duban-Bedu B; Diagnostic Préimplantatoire, Laboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Delobel B; Centre de Génétique Chromosomique, GH de l'Institut Catholique de Lille-Hopital Saint Vincent de Paul, Lille, France.
  • Vago P; Centre de Génétique Chromosomique, GH de l'Institut Catholique de Lille-Hopital Saint Vincent de Paul, Lille, France.
  • Vialard F; Cytogénétique Médicale, CHU Estaing, Clermont-Ferrand, France.
  • Gomes DM; U1240 Imagerie Moléculaire et Stratégies Théranostiques, Université Clermont Auvergne, INSERM, Clermont-Ferrand, France.
  • Siffroi JP; Unité de Cytogénétique, CHI de Poissy St Germain en Laye, Poissy, France.
  • Bonnefont JP; EA7404-GIG, UFR des Sciences de la Santé Simone Veil, UVSQ, Montigny-le-Bretonneux, France.
  • Dupont JM; Unité de Cytogénétique, CHI de Poissy St Germain en Laye, Poissy, France.
  • Jonveaux P; EA7404-GIG, UFR des Sciences de la Santé Simone Veil, UVSQ, Montigny-le-Bretonneux, France.
  • Doco-Fenzy M; Physiopathologie des Maladies Génétiques d'Expression Pédiatrique, Sorbonne Université, INSERM, Paris, France.
  • Sanlaville D; Service d'Histologie, Embryologie, Cytogénétique., Groupe Hospitalier Necker-Enfants Malades, Paris, France.
  • Le Caignec C; Laboratoire de Cytogénétique, HUPC Hôpital Cochin, APHP; Université Paris Descartes, Paris, France.
Prenat Diagn ; 39(11): 986-992, 2019 10.
Article in En | MEDLINE | ID: mdl-31273809
ABSTRACT

OBJECTIVE:

Uniparental disomy (UPD) testing is currently recommended during pregnancy in fetuses carrying a balanced Robertsonian translocation (ROB) involving chromosome 14 or 15, both chromosomes containing imprinted genes. The overall risk that such a fetus presents a UPD has been previously estimated to be around ~0.6-0.8%. However, because UPD are rare events and this estimate has been calculated from a number of studies of limited size, we have reevaluated the risk of UPD in fetuses for whom one of the parents was known to carry a nonhomologous ROB (NHROB).

METHOD:

We focused our multicentric study on NHROB involving chromosome 14 and/or 15. A total of 1747 UPD testing were performed in fetuses during pregnancy for the presence of UPD(14) and/or UPD(15).

RESULT:

All fetuses were negative except one with a UPD(14) associated with a maternally inherited rob(13;14).

CONCLUSION:

Considering these data, the risk of UPD following prenatal diagnosis of an inherited ROB involving chromosome 14 and/or 15 could be estimated to be around 0.06%, far less than the previous estimation. Importantly, the risk of miscarriage following an invasive prenatal sampling is higher than the risk of UPD. Therefore, we do not recommend prenatal testing for UPD for these pregnancies and parents should be reassured.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prenatal Diagnosis / Translocation, Genetic / Chromosomes, Human, Pair 14 / Chromosomes, Human, Pair 15 / Uniparental Disomy Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Pregnancy Language: En Journal: Prenat Diagn Year: 2019 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prenatal Diagnosis / Translocation, Genetic / Chromosomes, Human, Pair 14 / Chromosomes, Human, Pair 15 / Uniparental Disomy Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Pregnancy Language: En Journal: Prenat Diagn Year: 2019 Document type: Article Affiliation country: